The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Open accessAbstract
BACKGROUND: Septal reduction therapy (SRT), surgical myectomy or alcohol ablation, is recommended for obstructive hypertrophic cardiomyopathy (oHCM) patients with intractable symptoms despite maximal medical therapy, but is associated with morbidity and mortality. OBJECTIVES: This study sought to determine whether the oral myosin inhibitor mavacamten enables patients to improve sufficiently to no longer meet guideline criteria or choose to not undergo SRT. METHODS: Patients with left ventricular (LV) outflow tract (LVOT) gradient ≥50 mm Hg at rest/provocation who met guideline criteria for SRT were randomized, double blind, to mavacamten, 5 mg daily, or placebo, titrated up to 15 mg based on LVOT gradient and LV ejection fraction. The primary endpoint was the composite of the proportion of patients proceeding with SRT or who remained guideline-eligible after 16 weeks' treatment. RESULTS: One hundred and twelve oHCM patients were enrolled, mean age 60 ± 12 years, 51% men, 93% New York Heart Association (NYHA) functional class III/IV, with a mean post-exercise LVOT gradient of 84 ± 35.8 mm Hg. After 16 weeks, 43 of 56 placebo patients (76.8%) and 10 of 56 mavacamten patients (17.9%) met guideline criteria or underwent SRT, difference (58.9%; 95% CI: 44.0%-73.9%; P < 0.001). Hierarchical testing of secondary outcomes showed significant differences (P < 0.001) favoring mavacamten, mean differences in post-exercise peak LVOT gradient -37.2 mm Hg; ≥1 NYHA functional class improvement 41.1%; improvement in patient-reported outcome 9.4 points; and NT-proBNP and cardiac troponin I between-groups geometric mean ratio 0.33 and 0.53. CONCLUSIONS: In oHCM patients with intractable symptoms, mavacamten significantly reduced the fraction of patients meeting guideline criteria for SRT after 16 weeks. Long-term freedom from SRT remains to be determined. (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy [VALOR-HCM]; NCT04349072).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812
Self-citationBRAUNWALD, E., LAMBREW, C. T., ROCKOFF, S. D., ROSS, J., & MORROW, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Self-citationDiagnosis and Evaluation of Hypertrophic Cardiomyopathy
Maron, B. J., Desai, M. Y., Nishimura, R. A., Spirito, P., Rakowski, H., Towbin, J. A., Rowin, E. J., Maron, M. S., & Sherrid, M. V. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.002 · Cited by 637
Self-citationElliott, P. M., Gimeno, J. R., Tomé, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 427
Management of Hypertrophic Cardiomyopathy
Maron, B. J., Desai, M. Y., Nishimura, R. A., Spirito, P., Rakowski, H., Towbin, J. A., Dearani, J. A., Rowin, E. J., Maron, M. S., & Sherrid, M. V. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.021 · Cited by 398
Self-citationWoo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S., Ralph-Edwards, A., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 333
Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy: A Clinical Trial
Heitner, S. B., Jacoby, D., Lester, S. J., Owens, A., Wang, A., Zhang, D., Lambing, J., Lee, J., Semigran, M., & Sehnert, A. J. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3016 · Cited by 303
Self-citationKim, L. K., Swaminathan, R. V., Looser, P., Minutello, R. M., Wong, S. C., Bergman, G., Naidu, S. S., Gade, C. L. F., Charitakis, K., Singh, H. S., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0252 · Cited by 300
Self-citationSmedira, N. G., Lytle, B. W., Lever, H. M., Rajeswaran, J., Krishnaswamy, G., Kaple, R. K., Dolney, D. O. W., & Blackstone, E. H. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.063 · Cited by 271
Self-citationSpertus, J. A., Fine, J. T., Elliott, P., Ho, C. Y., Olivotto, I., Saberi, S., Li, W., Dolan, C., Reaney, M., Sehnert, A. J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00763-7 · Cited by 220
Self-citationLiebregts, M., Vriesendorp, P. A., Mahmoodi, B. K., Schinkel, A. F. L., Michels, M., & ten Berg, J. M. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.06.011 · Cited by 216
Desai, M. Y., Bhonsale, A., Smedira, N. G., Naji, P., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · Circulation · doi:10.1161/circulationaha.112.000849 · Cited by 193
Self-citationMORROW, A. G., & BRAUNWALD, E. (1959) · Circulation · doi:10.1161/01.cir.20.2.181 · Cited by 187
Low Operative Mortality Achieved With Surgical Septal Myectomy
Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Nishimura, R. A., Ralph-Edwards, A., Rakowski, H., Sherrid, M. V., Swistel, D. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1333 · Cited by 183
Self-citationLong-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy
Ball, W., Ivanov, J., Rakowski, H., Wigle, E. D., Linghorne, M., Ralph-Edwards, A., Williams, W. G., Schwartz, L., Guttman, A., & Woo, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.040 · Cited by 169
Panaich, S., Badheka, A. O., Chothani, A., Mehta, K. D., Patel, N., Deshmukh, A. J., Singh, V., Savani, G. T., Arora, S., Patel, N., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.075 · Cited by 135
Stern, J. A., Markova, S., Ueda, Y., Kim, J. B., Pascoe, P. J., Evanchik, M. J., Green, E. M., & Harris, S. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168407 · Cited by 135
Desai, M. Y., Wolski, K., OWENS, A. T., Naidu, S. S., Geske, J. B., Smedira, N. G., Schaff, H. V., Lampl, K. L., McErlean, E. S., Sewell, C., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.05.007 · Cited by 67
Self-citationWhy we need more septal myectomy surgeons: An emerging recognition
Maron, B. J., Dearani, J. A., Maron, M. S., Ommen, S. R., Rastegar, H., Nishimura, R. A., Swistel, D. G., Sherrid, M. V., Ralph-Edwards, A. C., Rakowski, H., et al. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.12.038 · Cited by 62
Self-citationDrug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
Sherrid, M. V. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x1201160126125403 · Cited by 52
Alashi, A., Smedira, N. G., Hodges, K., Popović, Z., Thamilarasan, M., Wierup, P. N., Lever, H. M., & Desai, M. Y. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016210 · Cited by 49
Self-citationClinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy
Wells, S. B., Rowin, E. J., Boll, G., Rastegar, H., Wang, W., Maron, M. S., & Maron, B. J. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.031 · Cited by 41
Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy
Nguyen, A. P., Schaff, H. V., Ommen, S. R., Gersh, B. J., Dearani, J. A., Geske, J. B., Lahr, B. D., & Nishimura, R. A. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.09.011 · Cited by 38
Self-citation
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Self-citation2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · JACC · doi:10.1016/j.jacc.2024.02.014 · Cited by 382
Self-citationAficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Maron, M. S., Masri, A., Nassif, M. E., Barriales-Villa, R., Arad, M., Cardim, N., Choudhury, L., Claggett, B., Coats, C. J., Düngen, H.-D., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2401424 · Cited by 348
Self-citationMavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy
Desai, M. Y., Owens, A. T., Abraham, T., Olivotto, I., Garcia-Pavia, P., Lopes, R. D., Elliott, P., Fernandes, F., Verheyen, N., Maier, L., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2505927 · Cited by 90
Self-citation
Metadata
- Authors
- Desai, M. Y., Owens, A., Geske, J. B., Wolski, K., Naidu, S. S., Smedira, N. G., Cremer, P. C., Schaff, H., McErlean, E., Sewell, C., Li, W., Sterling, L., Lampl, K., Edelberg, J. M., Sehnert, A. J., & Nissen, S. E.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 80
- Issue
- 2
- Pages
- 95-108
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4283804747
- Cited by
- 376
- References
- 28
- FWCI
- 47.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.